格雷斯海姆是制藥、生物技術和護膚品行業的全球合作伙伴，致力于為客戶提供全球領先的創新系統和解決方案。集團提供完整的藥品包裝解決方案、給藥系統和醫療裝置產品組合，并能為醫療保健行業提供綜合解決方案。公司產品范圍包括用于治療支持的數字解決方案、貼敷式注射器、預灌封注射器、注射筆、自助注射器和吸入器，以及西林瓶、安瓿瓶、固體塑料瓶、輸液套裝、滴眼劑瓶及糖漿瓶等產品組合。格雷斯海姆確保為患者提供安全的藥物輸送和可靠的給藥方式。格雷斯海姆通過沿價值鏈為客戶提供全面的服務，支持客戶應對日益增長的可持續發展需求。集團在歐洲、美洲和亞洲共16個國家設有超過40個生產基地，其業務遍布全球，并在全球不同區域市場實現本地化生產。集團現擁有13,400余名員工，2023年實現營業收入約20億歐元。德國格雷斯海姆集團(Gerresheimer AG)在法蘭克福證券交易所上市，被納入MDAX指數(ISIN：DE000A0LD6E6)。
Gerresheimer is an innovative systems and solutions provider and a global partner for the pharma, biotech and cosmetic industries. The Group offers a comprehensive portfolio of drug containment solutions including closures and accessories, as well as drug delivery systems, medical devices and solutions for the health industry. The product range includes digital solutions for therapy support, medication pumps, syringes, pens, auto-injectors and inhalers as well as vials, cartridges, ampoules, tablet containers, infusion, dropper and syrup bottles and more. Gerresheimer ensures the safe delivery and reliable administration of drugs to the patient. Gerresheimer supports its customers with comprehensive services along the value chain and in addressing the growing demａnd for enhanced sustainability. With over 40 production sites in 16 countries in Europe, America and Asia, Gerresheimer has a global presence and produces locally for regional markets. The Group generated revenues of around €2bn in 2023 and currently employs around 13,400 people. Gerresheimer AG is listed in the MDAX on the Frankfurt Stock Exchange (ISIN: DE000A0LD6E6).
